Offer - Urjas Oil for just Rs 1 X
Telvas LN is an allopathic medicine The correct dosage of Telvas LN depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Telvas LN is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Telvas LN safe for pregnant women?
Telvas LN can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Telvas LN safe during breastfeeding?
Telvas LN may have very limited harmful effects for breastfeeding women.
What is the effect of Telvas LN on the Kidneys?
Telvas LN is not harmful for kidneys.
What is the effect of Telvas LN on the Liver?
Telvas LN is rarely harmful for the liver.
What is the effect of Telvas LN on the Heart?
Very few cases of side effects of Telvas LN on the heart have been reported.
Telvas LN should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Telvas LN unless your doctor advises you to do so -
Is this Telvas LN habit forming or addictive?
Forming a habit of Telvas LN has not been reported.
Interaction between Food and Telvas LN
When consumed with certain foods, Telvas LN may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Telvas LN
Consumption of alcohol and Telvas LN together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)